Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
Perspective Therapeutics
Novartis
VM Oncology, LLC
Actym Therapeutics, Inc.
Incyte Corporation
A2 Biotherapeutics Inc.
Cancer Research UK
Checkpoint Therapeutics, Inc.
Aminex Therapeutics, Inc.
Mabpro, a.s.
Jules Bordet Institute
Quadriga Biosciences, Inc.
Xencor, Inc.
AbbVie
Shionogi Inc.
Masonic Cancer Center, University of Minnesota
Stanford University
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Chicago